THE DEAL, AT A GLANCE
From the announcementAstek Diagnostics
What it doesAstek is building the Jiddu Platform, a system designed to deliver antibiotic susceptibility results in under an hour, compared with the 48 to 72 hours needed by…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Who is involvedBacked by TEDCO, the Maryland Technology Development Corporation, its Pre-Seed Builder Fund, Venture FundsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedAstek Diagnostics raised $0.8M Pre-Seed, announced 2026-08-25From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersAstek Diagnostics is advancing a rapid antibiotic susceptibility testing platform from funded concept toward first clinical placement and regulatory clearance.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Astek Diagnostics · Financing Record
Explore source-linked visual explanations for Astek Diagnostics. Unsupported claims are withheld while source review continues.
Record 11227 · Recorded date: 2026-08-25
Explore company records →